Identification of cough variant asthma phenotypes based on clinical and pathophysiological data

Wenzhi Zhan,Feng Wu,Yunhui Zhang,Lin Lin,Wen Li,Wei Luo,Fang Yi,Yuanrong Dai,Suyun Li,Jiangtao Lin,Yadong Yuan,Chen Qiu,Yong Jiang,Limin Zhao,Meihua Chen,Zhongmin Qiu,Ruchong Chen,Jiaxing Xie,Chunxing Guo,Mei Jiang,Xiaohong Yang,Guochao Shi,Dejun Sun,Rongchang Chen,Nanshan Zhong,Huahao Shen,Kefang Lai
DOI: https://doi.org/10.1016/j.jaci.2023.04.017
IF: 14.29
2023-05-13
Journal of Allergy and Clinical Immunology
Abstract:Background Cough variant asthma (CVA) may respond differently to anti-asthmatic treatment. There is limited data on the heterogeneity of CVA. Objective We aimed to classify patients with CVA using cluster analysis based on clinico-physiological parameters and to unveil the underlying molecular pathways of these phenotypes with transcriptomic data of sputum cells. Methods K-mean clustering was applied to 342 newly physician-diagnosed patients with CVA from a prospective, multicenter, observational cohort using 10 pre-specified baseline clinic-pathophysiological variables. The clusters were compared based on clinical features, treatment response and sputum transcriptomic data. Results Three stable CVA clusters were identified. Cluster 1 (n= 176) was characterized by female predominance, late-onset, normal lung function, and a low proportion of complete resolution of cough (60.8%) after anti-asthmatic treatment. Cluster 2 (n=105) presented with young, nocturnal cough, atopy, type 2-high inflammation, and a high proportion of complete resolution of cough (73.3%) with highly upregulated co-expression gene network that related to type 2 immunity. Cluster 3 (n= 61) had a high body mass index, long duration, family history of asthma, low lung function, and low proportion of complete resolution of cough (54.1%). Th17 immunity and type 2 immunity co-expression gene networks were both upregulated in clusters 1 and 3. Conclusion Three clusters of CVA were identified with different clinical, pathophysiological, and transcriptomic features and responses to anti-asthmatics treatment, which may improve our understanding of pathogenesis and develop individualized treatment of cough in asthma.
immunology,allergy
What problem does this paper attempt to address?